Business Wire

The ‘Lady Blunt’ Stradivarius Violin Sets World Record Price at Tarisio Auction

Share
TARISIO

Sold for £9.808.000 to private bidder

Tarisio, the online auction house for fine instruments, sold the ‘Lady Blunt’ Stradivarius violin of 1721 for a world-record price of £9,808,000 ($15,894,000) at their June 20 auction, over 4 times the previous auction record for a Stradivari violin. It was bought by an anonymous bidder after extremely active bidding. 100% of proceeds from the sale will go to aid Japan through the Nippon Foundation’s Northeastern Japan Earthquake and Tsunami Relief Fund.

The sale of the ‘Lady Blunt’ sparked massive interest from collectors around the globe, eager for the unique opportunity to own a piece of history. Owned for 30 years by Lady Anne Blunt, granddaughter of the famous English poet Lord Byron, the violin has also belonged to the famed Parisian dealer Jean Baptiste Vuillaume, the collectors Richard Bennett, the Baron Knoop and Sam Bloomfield, and The Nippon Music Foundation. Remarkably, as Andrew Hill of the W. E. Hill firm points out, the violin “…is in much the same condition as when it left its maker’s hands.”

Antonio Stradivari produced violins, violas and cellos in Cremona, Italy, of which some 600 are still in existence. His instruments are in high demand by the world’s great soloists and the most discerning collectors. Of the Stradivari violins that are still in private hands the ‘Lady Blunt’ is said to be in the most pure condition with the most original features and its varnish still mainly undisturbed.

This was the first time that the violin has sold publicly since 1971 when it was sold at Sotheby’s for £84,000, also a world record at the time. The ‘Lady Blunt’ was offered for sale this year by The Nippon Music Foundation, owners of a number of the world’s finest Stradivari and Guarneri instruments. Says Ms. Kazuko Shiomi, President of the Nippon Music Foundation, “While this violin was very important to our collection, the needs of our fellow Japanese people after the March 11 tragedy have proven that we all need to help, in any way we can. The donation will be put to immediate use on the ground in Japan.”

Jason Price, Director of Tarisio, said, “We are deeply honored that we were able to facilitate such a historic sale for such a worthy cause. The ‘Lady Blunt’ is without doubt the best-preserved Stradivarius to come on the market in 40 years and this was truly a once in a lifetime sale for everyone involved.”

ABOUT TARISIO

Tarisio is one of the world’s leading sources of fine and rare stringed instruments. Launched in 1999, it brought a fresh approach to the instrument market, combining the services of a traditional auction house with the efficiency and accessibility of online sales. Offering first-class expertise and guaranteed cataloging, Tarisio quickly earned the respect of musicians, collectors, restorers and members of the trade the world over. It now sells over 2,000 violins, violas, cellos, and bows each year, with offices in New York and London. http://www.tarisio.com

Contact:

hyperlaine
Scott Laine, +1-646-662-9639
scott@hyperlaine.com

About Business Wire

Business Wire
Business Wire
101 California Street, 20th Floor
CA 94111 San Francisco

http://businesswire.com

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

SBC Medical added to membership of Russell 3000® Index28.6.2025 01:30:00 CEST | Press release

SBC Medical Group Holdings Incorporated (Nasdaq: SBC) (“SBC Medical”), a global franchise and provider of services for aesthetic clinics, has been added as a member of the broad-market Russell 3000® Index, effective after the US market opens on June 30, as part of the 2025 Russell indexes reconstitution. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250608244276/en/ Yoshiyuki Aikawa-Director (Chairman), CEO Membership in the Russell 3000® Index, which remains in place for one year, means automatic inclusion in the large-cap Russell 1000® Index or small-cap Russell 2000®Index as well as the appropriate growth and value style indexes. Russell indexes are widely used by investment managers and institutional investors for index funds and as benchmarks for active investment strategies. According to the data as of the end of June 2024, about $10.6 trillion in assets are benchmarked against the Russell US indexes, which belong to

Altimetrik and SLK Software Join Forces to Create an AI-First Engineering Services Powerhouse27.6.2025 22:44:00 CEST | Press release

Altimetrik, a pure-play AI, Data and Digital engineering solutions company, today announced the signing of a definitive agreement to acquire SLK Software (“SLK”), a global technology services firm focused on delivering AI, intelligence automation and analytics solutions. The acquisition will further strengthen Altimetrik’s end-to-end enablement services and expand its customer reach, with a clear path to accelerate towards Altimetrik’s goal of reaching $1billion in annual revenue. The transaction remains subject to customary closing conditions and is expected to close in the second half of 2025. Financial details were not disclosed. Founded in 2000, SLK is recognized as a leader in the tech industry, and for its commitment to create innovative digital solutions. This strategic acquisition will significantly enhance the scale of Altimetrik’s capabilities, bringing together Altimetrik’s AI-first, platform-native engineering model and SLK’s full technology services stack that will further

Andersen Consulting udvider sine kompetencer inden for forretningstransformation med tilføjelsen af The Clearing27.6.2025 16:48:00 CEST | Pressemeddelelse

Andersen Consulting udbygger sin platform med samarbejdsfirmaet The Clearing, som er en managementkonsulentvirksomhed med speciale i organisatorisk omstilling og lederudvikling. The Clearing blev stiftet i 2009 og rådgiver kunder om komplekse udfordringer ved at afstemme ledelse, strategi, kultur og drift. Firmaet arbejder med føderale agenturer, virksomheder og nonprofitorganisationer med henblik på at skabe målbare forandringer på tværs af forskellige interessenter til gavn for en leders vision og strategi. Med dyb erfaring inden for flere sektorer, herunder national sikkerhed, sundhedspleje og finansielle tjenester, leder The Clearings unikke blanding af talent med ekspertise inden for organisationsudvikling, dataanalyse og visuel rådgivning forretningstransformationer i stor skala og arbejder sammen med kunder og eksperter for at sikre, at rådgivning omsættes til implementering. "Vi leverer transformative resultater, der ikke kun er i overensstemmelse med strategiske mål, men også

PRD Therapeutics Announces Initiation of First-in-Human Study for PRD00127.6.2025 16:00:00 CEST | Press release

PRD Therapeutics, Inc., a clinical stage company focused on the development of novel lipid metabolism regulators targeting homozygous familial hypercholesterolemia (HoFH) and metabolic dysfunction associated fatty liver disease (MASH/MASLD), today announced that the company recently initiated dosing in a First-in-Human (FIH) clinical trial of PRD001, a first-in-class SOAT2 (formerly known as ACAT2) selective inhibitor. “We are excited to initiate dosing in this clinical trial of PRD001. Many clinical trials have been conducted on SOAT1/2 dual or SOAT1 selective inhibitors, but this is the first clinical trial of an SOAT2 selective inhibitor” said Kanji Hosoda, Ph.D., CEO and co-founder of PRD Therapeutics. “Several results with SOAT1 or 2 knockout mice have been published, suggesting that knocking out or inhibiting only SOAT2 is crucial to demonstrate safety and efficacy. PRD001 is the world's first and only SOAT2-selective inhibitor and is expected to exhibit safety and efficacy in hu

STEMCELL Technologies Introduces STEMprep™ Tissue Dissociator System to Accelerate Research Discoveries27.6.2025 14:00:00 CEST | Press release

New instrument automates tissue processing for researchers in cancer, immunology and other science fields To help scientists accelerate their workflows, STEMCELL Technologies has commercially launched the STEMprep™ Tissue Dissociator System—a new benchtop instrument that automates, standardizes, and streamlines tissue dissociation, the process of breaking down tissue samples into single-cell suspensions for research purposes. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250627342791/en/ To help scientists accelerate their workflows, STEMCELL Technologies has commercially launched the STEMprep™ Tissue Dissociator System—a new benchtop instrument that automates, standardizes, and streamlines tissue dissociation, the process of breaking down tissue samples into single-cell suspensions for research purposes. “Tissue dissociation is incredibly important for making advancements in research fields, like cancer and immunology, yet

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye